Patent Attorney Urges High Court To Decline Review Of 9th Circuit FCA Reversal
WASHINGTON, D.C. — A patent attorney who was a district court’s qui tam plaintiff in a suit accusing pharmaceutical companies of violating the False Claims Act (FCA) by artificially inflating drug...To view the full article, register now.
Already a subscriber? Click here to view full article